- call +1-201-465-4211
- email sales@mrinsights.biz
Neuromodulation is a process that makes use of an implantable medical device to modulate and alter neural activities for therapeutic purposes. Devices that are used for neuromodulation are called as neurostimulators or neurostimulation devices and usually function by bringing about stimulation of nerve impulses or by inhibition of pain signals produced at target sites that include autonomic nervous system, deep nuclei of the brain, peripheral nervous system, and central nervous system.
Scope of the Report:
This report focuses on the Neurosimulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Neurosimulation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific
Abbott
Cyberonics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sacral Nerve Stimulators
Spinal Cord Stimulators
Gastric Electric Stimulators
Deep Brain Stimulators
Vagus Nerve Stimulators
Market Segment by Applications, can be divided into
Epilepsy
Depression
Dystonia
Pain Management
Parkinson’s Disease
Others
There are 15 Chapters to deeply display the global Neurosimulation market.
Chapter 1, to describe Neurosimulation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Neurosimulation, with sales, revenue, and price of Neurosimulation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Neurosimulation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Neurosimulation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Neurosimulation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Neurosimulation Introduction
1.2 Market Analysis by Type
1.2.1 Sacral Nerve Stimulators
1.2.2 Spinal Cord Stimulators
1.2.3 Gastric Electric Stimulators
1.2.4 Deep Brain Stimulators
1.2.5 Vagus Nerve Stimulators
1.3 Market Analysis by Applications
1.3.1 Epilepsy
1.3.2 Depression
1.3.3 Dystonia
1.3.4 Pain Management
1.3.5 Parkinson’s Disease
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Neurosimulation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Neurosimulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific
2.2.1 Business Overview
2.2.2 Neurosimulation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Neurosimulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Neurosimulation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Neurosimulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cyberonics
2.4.1 Business Overview
2.4.2 Neurosimulation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cyberonics Neurosimulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neurosimulation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Neurosimulation Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neurosimulation Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Neurosimulation Manufacturer Market Share in 2017
3.3.2 Top 6 Neurosimulation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Neurosimulation Market Analysis by Regions
4.1 Global Neurosimulation Sales, Revenue and Market Share by Regions
4.1.1 Global Neurosimulation Sales and Market Share by Regions (2013-2018)
4.1.2 Global Neurosimulation Revenue and Market Share by Regions (2013-2018)
4.2 North America Neurosimulation Sales and Growth Rate (2013-2018)
4.3 Europe Neurosimulation Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurosimulation Sales and Growth Rate (2013-2018)
4.5 South America Neurosimulation Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurosimulation Sales and Growth Rate (2013-2018)
5 North America Neurosimulation by Countries
5.1 North America Neurosimulation Sales, Revenue and Market Share by Countries
5.1.1 North America Neurosimulation Sales and Market Share by Countries (2013-2018)
5.1.2 North America Neurosimulation Revenue and Market Share by Countries (2013-2018)
5.2 United States Neurosimulation Sales and Growth Rate (2013-2018)
5.3 Canada Neurosimulation Sales and Growth Rate (2013-2018)
5.4 Mexico Neurosimulation Sales and Growth Rate (2013-2018)
6 Europe Neurosimulation by Countries
6.1 Europe Neurosimulation Sales, Revenue and Market Share by Countries
6.1.1 Europe Neurosimulation Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Neurosimulation Revenue and Market Share by Countries (2013-2018)
6.2 Germany Neurosimulation Sales and Growth Rate (2013-2018)
6.3 UK Neurosimulation Sales and Growth Rate (2013-2018)
6.4 France Neurosimulation Sales and Growth Rate (2013-2018)
6.5 Russia Neurosimulation Sales and Growth Rate (2013-2018)
6.6 Italy Neurosimulation Sales and Growth Rate (2013-2018)
7 Asia-Pacific Neurosimulation by Countries
7.1 Asia-Pacific Neurosimulation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neurosimulation Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Neurosimulation Revenue and Market Share by Countries (2013-2018)
7.2 China Neurosimulation Sales and Growth Rate (2013-2018)
7.3 Japan Neurosimulation Sales and Growth Rate (2013-2018)
7.4 Korea Neurosimulation Sales and Growth Rate (2013-2018)
7.5 India Neurosimulation Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Neurosimulation Sales and Growth Rate (2013-2018)
8 South America Neurosimulation by Countries
8.1 South America Neurosimulation Sales, Revenue and Market Share by Countries
8.1.1 South America Neurosimulation Sales and Market Share by Countries (2013-2018)
8.1.2 South America Neurosimulation Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Neurosimulation Sales and Growth Rate (2013-2018)
8.3 Argentina Neurosimulation Sales and Growth Rate (2013-2018)
8.4 Colombia Neurosimulation Sales and Growth Rate (2013-2018)
9 Middle East and Africa Neurosimulation by Countries
9.1 Middle East and Africa Neurosimulation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neurosimulation Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Neurosimulation Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Neurosimulation Sales and Growth Rate (2013-2018)
9.3 UAE Neurosimulation Sales and Growth Rate (2013-2018)
9.4 Egypt Neurosimulation Sales and Growth Rate (2013-2018)
9.5 Nigeria Neurosimulation Sales and Growth Rate (2013-2018)
9.6 South Africa Neurosimulation Sales and Growth Rate (2013-2018)
10 Global Neurosimulation Market Segment by Type
10.1 Global Neurosimulation Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Neurosimulation Sales and Market Share by Type (2013-2018)
10.1.2 Global Neurosimulation Revenue and Market Share by Type (2013-2018)
10.2 Sacral Nerve Stimulators Sales Growth and Price
10.2.1 Global Sacral Nerve Stimulators Sales Growth (2013-2018)
10.2.2 Global Sacral Nerve Stimulators Price (2013-2018)
10.3 Spinal Cord Stimulators Sales Growth and Price
10.3.1 Global Spinal Cord Stimulators Sales Growth (2013-2018)
10.3.2 Global Spinal Cord Stimulators Price (2013-2018)
10.4 Gastric Electric Stimulators Sales Growth and Price
10.4.1 Global Gastric Electric Stimulators Sales Growth (2013-2018)
10.4.2 Global Gastric Electric Stimulators Price (2013-2018)
10.5 Deep Brain Stimulators Sales Growth and Price
10.5.1 Global Deep Brain Stimulators Sales Growth (2013-2018)
10.5.2 Global Deep Brain Stimulators Price (2013-2018)
10.6 Vagus Nerve Stimulators Sales Growth and Price
10.6.1 Global Vagus Nerve Stimulators Sales Growth (2013-2018)
10.6.2 Global Vagus Nerve Stimulators Price (2013-2018)
11 Global Neurosimulation Market Segment by Application
11.1 Global Neurosimulation Sales Market Share by Application (2013-2018)
11.2 Epilepsy Sales Growth (2013-2018)
11.3 Depression Sales Growth (2013-2018)
11.4 Dystonia Sales Growth (2013-2018)
11.5 Pain Management Sales Growth (2013-2018)
11.6 Parkinson’s Disease Sales Growth (2013-2018)
11.7 Others Sales Growth (2013-2018)
12 Neurosimulation Market Forecast (2018-2023)
12.1 Global Neurosimulation Sales, Revenue and Growth Rate (2018-2023)
12.2 Neurosimulation Market Forecast by Regions (2018-2023)
12.2.1 North America Neurosimulation Market Forecast (2018-2023)
12.2.2 Europe Neurosimulation Market Forecast (2018-2023)
12.2.3 Asia-Pacific Neurosimulation Market Forecast (2018-2023)
12.2.4 South America Neurosimulation Market Forecast (2018-2023)
12.2.5 Middle East and Africa Neurosimulation Market Forecast (2018-2023)
12.3 Neurosimulation Market Forecast by Type (2018-2023)
12.3.1 Global Neurosimulation Sales Forecast by Type (2018-2023)
12.3.2 Global Neurosimulation Market Share Forecast by Type (2018-2023)
12.4 Neurosimulation Market Forecast by Application (2018-2023)
12.4.1 Global Neurosimulation Sales Forecast by Application (2018-2023)
12.4.2 Global Neurosimulation Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Neurosimulation Picture
Table Product Specifications of Neurosimulation
Figure Global Sales Market Share of Neurosimulation by Types in 2017
Table Neuro
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
